July 31, 2014 5:54 AM ET

Biotechnology

Company Overview of Sangart, Inc.

Company Overview

Sangart, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of oxygen therapeutics. It offers Hemospan, a human hemoglobin-based product that delivers oxygen to tissues at risk of oxygen deprivation. The company’s MP4CO, a biopharmaceutical product is used for the treatment of acute painful sickling crises in patients with sickle cell disease. Sangart, Inc. was founded in 1998 and is based in San Diego, California.

6175 Lusk Boulevard

San Diego, CA 92121

United States

Founded in 1998

Phone:

858-450-2400

Fax:

858-450-2499

Key Executives for Sangart, Inc.

Chief Executive Officer
Age: 45
Chief Financial Officer and General Counsel
Chief Operating Officer
Chief Commercial Officer
Chief Medical Officer
Compensation as of Fiscal Year 2014.

Sangart, Inc. Key Developments

Sangart, Inc. Presents at The BIOCOM 3rd Annual Global Life Science Partnering Conference, Feb-27-2013

Sangart, Inc. Presents at The BIOCOM 3rd Annual Global Life Science Partnering Conference, Feb-27-2013 . Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States.

Sangart, Inc. Completes Patient Enrollment In Phase 2B Clinical Trial Of MP4OX in Traumatic Hemorrhagic Shock Patients

Sangart, Inc. announced the completion of patient enrollment in its Phase 2b study designed to evaluate the efficacy and safety of MP4OX treatment in severely injured trauma patients experiencing hemorrhagic shock. MP4OX is a novel ischemic rescue therapy designed to improve perfusion and oxygen delivery to tissues. The clinical trial was a multi-center, randomized, double-blind, controlled study that enrolled patients suffering from hemorrhagic shock with lactic acidosis at 53 trial sites in 15 countries. The primary endpoint of the study is the proportion of patients able to be discharged alive from the hospital within 28 days following the trauma.

Similar Private Companies By Industry

Company Name Region
Altea Therapeutics Corporation United States
Grifols Inc. United States
Pluvita Corporation United States
Matritech, Inc. United States
Stem Cell Theranostics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sangart, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.